Triamcinolone Ointment vs. Cream for Plaque Psoriasis
For plaque psoriasis, ointment formulations are generally preferred over cream formulations due to superior occlusive properties and enhanced drug penetration, though the AAD-NPF guidelines list both triamcinolone acetonide 0.1% ointment and cream as acceptable mid-potency options without explicitly ranking one superior to the other.
Vehicle Selection Principles
The choice between ointment and cream formulations depends on several clinical factors:
Ointment Advantages
- Greater occlusion leads to enhanced corticosteroid penetration into psoriatic plaques
- More effective for thick, hyperkeratotic lesions characteristic of chronic plaque psoriasis
- Provides better moisturization for dry, scaly plaques
- Generally more potent due to increased bioavailability
Cream Advantages
- Better cosmetic acceptability with less greasy residue
- Preferred for intertriginous areas and facial psoriasis where occlusion may cause maceration
- More suitable for hairy areas including scalp margins
- Better patient adherence due to ease of application
Guideline Context
The 2021 Joint AAD-NPF Guidelines 1 classify triamcinolone acetonide formulations by potency class rather than vehicle type:
- Triamcinolone acetonide 0.5% (ointment): Class III (high potency)
- Triamcinolone acetonide 0.1% (ointment and cream): Class IV-V (medium potency)
- Triamcinolone acetonide 0.025% (cream): Class VI (lower-medium potency)
The guidelines emphasize that topical corticosteroids "provide high efficacy and good safety" and "play a key role in the treatment of psoriasis, especially for localized disease" 1, but do not make vehicle-specific recommendations for triamcinolone.
Supporting Evidence
A 1988 comparative study 2 demonstrated that ointment formulations generally outperform cream formulations when comparing different corticosteroids. The study showed mometasone ointment was significantly more effective than its cream counterpart, supporting the principle that ointment vehicles enhance efficacy.
Clinical Algorithm
For typical plaque psoriasis:
- Start with ointment for body plaques, especially if thick/hyperkeratotic
- Consider cream for face, flexures, or scalp margins where ointment is impractical
- Switch to cream if patient adherence is poor due to greasiness concerns
Concentration matters more than vehicle: The 0.5% ointment formulation (Class III) is significantly more potent than the 0.1% formulations regardless of vehicle 1.
Important Caveats
- The FDA label 3 indicates triamcinolone acetonide cream 0.1% for "corticosteroid-responsive dermatoses" without vehicle preference
- No head-to-head trials directly compare triamcinolone ointment vs. cream specifically for plaque psoriasis
- Patient preference significantly impacts adherence—a less potent formulation used consistently may outperform a more potent one used sporadically
- For localized resistant plaques, consider intralesional triamcinolone (5 mg/mL) which showed 62.5% complete clearance rates 4
The practical recommendation: Use ointment for body plaques when feasible, reserving cream for cosmetically sensitive areas or when patient preference dictates.